Clinical Trials · NCT04963712
Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder
- Phase
- EARLY_Phase 1
- Recruitment status
- Completed
- Sponsor
- Shanghai Public Health Clinical Center
- Enrollment
- 20
- Start date
- Sep 2021
- Locations
- 1 site, China
- Primary endpoint
- Change in CD4+T cell counts